| J1602 | Injection, golimumab, 1 mg, for intravenous use | 23,690 | $10 | $260.6K |
| J0897 | Injection, denosumab, 1 mg | 10,500 | $20 | $189K |
| J3262 | Injection, tocilizumab, 1 mg | 33,380 | $10 | $166.9K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 19,950 | $10 | $159.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 570 | $90 | $50.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 290 | $130 | $37.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 360 | $100 | $35.2K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 370 | $50 | $19.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 150 | $120 | $18K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 120 | $60 | $7.7K |